Literature DB >> 336374

Hemostatic abnormalities associated with malignant diseases.

H Rasche, M Dietrich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336374     DOI: 10.1016/0014-2964(77)90001-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  8 in total

Review 1.  Non-tissue factor procoagulants in cancer cells.

Authors:  S G Gordon; M Chelladurai
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Low-dose heparin in the management of acute myelocytic leukaemia.

Authors:  M R Nowrousian; P Hilgard
Journal:  Blut       Date:  1978-12-15

3.  Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile.

Authors:  R Sawaya; P Glas-Greenwalt
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

Review 4.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant disease.

Authors:  Z Gilead; R Zahavi; A Hatzubai; G Brufman; S Biran; D Sulitzeanu
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

Review 6.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

Review 7.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Tumour sublines with different metastatic capacity induce similar blood coagulation changes in the host.

Authors:  F Delaini; R Giavazzi; G De Bellis Vitti; G Alessandri; A Mantovani; M B Donati
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.